Net Earnings (Loss) per Share

9 Months Ended

Sep. 30, 2023

Net Earnings (Loss) per ShareThe basic weighted average shares and common stock equivalents for the three and nine months ended September 30, 2023 and 2022, were computed using the treasury stock method.

The following table summarizes net earnings and net earnings per share attributable to FIS common stockholders for the three and nine months ended September 30, 2023 and 2022 (in millions, except per share amounts):


	Three months ended September 30,				Nine months ended September 30,
	2023		2022		2023		2022
Net earnings (loss) from continuing operations attributable to FIS common stockholders	$	260	$	218	$	440	$	499
Net earnings (loss) from discontinued operations attributable to FIS common stockholders	(709)		31		(7,345)		147
Net earnings (loss) attributable to FIS common stockholders	$	(449)	$	249	$	(6,905)	$	646
Weighted average shares outstanding-basic	592		605		592		608
Plus: Common stock equivalent shares	—		2		—		3
Weighted average shares outstanding-diluted	592		607		592		611
Net earnings (loss) per share-basic from continuing operations attributable to FIS common stockholders	$	0.44	$	0.36	$	0.74	$	0.82
Net earnings (loss) per share-basic from discontinued operations attributable to FIS common stockholders	(1.20)		0.05		(12.41)		0.24
Net earnings (loss) per share-basic attributable to FIS common stockholders	$	(0.76)	$	0.41	$	(11.66)	$	1.06
Net earnings (loss) per share-diluted from continuing operations attributable to FIS common stockholders	$	0.44	$	0.36	$	0.74	$	0.82
Net earnings (loss) per share-diluted from discontinued operations attributable to FIS common stockholders	(1.20)		0.05		(12.41)		0.24
Net earnings (loss) per share-diluted attributable to FIS common stockholders	$	(0.76)	$	0.41	$	(11.66)	$	1.06

The diluted net loss per share for the three and nine months ended September 30, 2023, did not include the effect of common stock equivalent shares of 2 million and 2 million, respectively, because the effect would have been anti-dilutive. For the three and nine months ended September 30, 2023, options to purchase approximately 8 million shares of our common stock were not included in the computation of diluted earnings per share because they were anti-dilutive. For the three and nine months ended September 30, 2022, options to purchase approximately 5 million and 4 million shares, respectively, of our common stock were not included in the computation of diluted earnings per share because they were anti-dilutive.

In January 2021, our Board of Directors approved a share repurchase program under which it authorized the Company to repurchase up to 100 million shares of our common stock at management's discretion from time to time on the open market or in privately negotiated transactions and through Rule 10b5-1 plans. The new repurchase program has no expiration date and may be suspended for periods, amended or discontinued at any time. Approximately 64 million shares remained available for repurchase as of September 30, 2023.